News Briefs: Cleveland Sues PBMs Over Insulin Prices
The City of Cleveland on July 24 filed a lawsuit against PBMs and drug manufacturers, alleging they “orchestrated a pricing scheme that resulted in skyrocketing insulin prices and cost the city millions of dollars in prescription benefit payouts.” The companies named in the lawsuit include The Cigna Group’s Evernorth and its PBM/pharmacy subsidiaries Express Scripts, Medco Health Solutions and ESI Mail Pharmacy Services; CVS Health Corp. And its Caremark division; UnitedHealth Group and its Optum, Optum Rx and Optum Insight subsidiaries; as well as Eli Lilly & Co., Novo Nordisk Inc., and Sanofi-Aventis U.S. LLC. Cleveland is the first city to file such a suit; California filed a similar complaint in January, however, accusing largely the same companies of insulin price-fixing.
Related Posts
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile